
MAYS Valuation
J W Mays Inc
- Overview
- Forecast
- Valuation
- Earnings
MAYS Relative Valuation
MAYS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MAYS is overvalued; if below, it's undervalued.
Historical Valuation
J W Mays Inc (MAYS) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of J W Mays Inc (MAYS) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:37.40
Fair
0.00
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
J W Mays Inc. (MAYS) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.00
EV/EBIT
J W Mays Inc. (MAYS) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.
0.00
PS
J W Mays Inc. (MAYS) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
J W Mays Inc. (MAYS) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
J W Mays Inc. (MAYS) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
J W Mays Inc (MAYS) has a current Price-to-Book (P/B) ratio of 1.43. Compared to its 3-year average P/B ratio of 1.53 , the current P/B ratio is approximately -6.87% higher. Relative to its 5-year average P/B ratio of 1.53, the current P/B ratio is about -6.87% higher. J W Mays Inc (MAYS) has a Forward Free Cash Flow (FCF) yield of approximately 2.55%. Compared to its 3-year average FCF yield of 2.26%, the current FCF yield is approximately 12.91% lower. Relative to its 5-year average FCF yield of 2.26% , the current FCF yield is about 12.91% lower.
1.43
P/B
Median3y
1.53
Median5y
1.53
2.55
FCF Yield
Median3y
2.26
Median5y
2.26
Competitors Valuation Multiple
The average P/S ratio for MAYS's competitors is 0.76, providing a benchmark for relative valuation. J W Mays Inc Corp (MAYS) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of 4.99%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of MAYS decreased by 13.61% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -358.91 to -1.00K.
The secondary factor is the Revenue Growth, contributed 4.99%to the performance.
Overall, the performance of MAYS in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch

MODV
ModivCare Inc
2.350
USD
0.00%

ALXO
ALX Oncology Holdings Inc
0.644
USD
0.00%

DYCQ
DT Cloud Acquisition Corp
10.980
USD
0.00%

CAMP
CAMP4 Therapeutics Corp
1.880
USD
+12.57%

IROH
Iron Horse Acquisitions Corp
8.260
USD
+18.00%

ASMB
Assembly Biosciences Inc
25.910
USD
+1.85%

MLSS
Milestone Scientific Inc
0.657
USD
+1.08%

RBOT
Vicarious Surgical Inc
6.520
USD
-4.96%

ORMP
Oramed Pharmaceuticals Inc
2.095
USD
+0.72%

BKHA
Black Hawk Acquisition Corp
10.983
USD
+0.21%
FAQ

Is J W Mays Inc (MAYS) currently overvalued or undervalued?
J W Mays Inc (MAYS) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of J W Mays Inc (MAYS) is between to according to relative valuation methord.

What is J W Mays Inc (MAYS) fair value?

How does MAYS's valuation metrics compare to the industry average?

What is the current P/B ratio for J W Mays Inc (MAYS) as of Aug 18 2025?

What is the current FCF Yield for J W Mays Inc (MAYS) as of Aug 18 2025?

What is the current Forward P/E ratio for J W Mays Inc (MAYS) as of Aug 18 2025?
